THE WHAT The Courtin-Clarins family is set to acquire clean beauty brand Ilia via its holding company Famille C, according to a report by WWD.com.
THE DETAILS Financial details of the deal weren’t disclosed.
It is reported that Prisca Courtin-Clarins, Deputy Chief Executive Officer of Famille C, contacted Ilia three years ago.
Talking to WWD, she said, “It’s my role in Famille C to identify the brands of tomorrow and therefore diversity the family’s assets. Ilia is Famille C’s first major and strategic acquisition. The idea is to make it the worldwide leader in clean color [cosmetics].”
Ilia has a ‘motto for clean,’ using organic and natural bases. While it has a tight focus on its own website in the U.S., it is also distributed in Space NK, Credo and Mecca.
THE WHY While there were said to be other suitors for Ilia, Courtins-Clarins says there are similarities between the two companies.
She said, “We are very careful in the sourcing of our ingredients, and it’s an essential point for Ilia — also the product quality and efficacy.”
Through the buy-out, Ilia will promote innovation in the beauty and well-being field.
According to Jonathan Zrihen, President and CEO of Groupe Clarins, the acquisition is “in line with the ambitions of the Courtin-Clarins family: remaining on the cutting-edge to develop sustainable beauty for tomorrow.”
He continued, “Ilia is an amazing brand managed by a great team. I am truly convinced that this operation will enable Ilia to benefit from both Famille C and Clarins expertise to further accelerate and conquer new territories.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
